Where I see patients (2)
My reviews
Selected research
-
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review.
Expert opinion on investigational drugs
-
Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma.
Leukemia & lymphoma
5.0